Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 06 04:00PM ET
2.52
Dollar change
+0.33
Percentage change
15.07
%
Index- P/E- EPS (ttm)-9.24 Insider Own0.52% Shs Outstand9.44M Perf Week-4.55%
Market Cap23.77M Forward P/E- EPS next Y-1.16 Insider Trans19.49% Shs Float9.39M Perf Month37.70%
Income-24.32M PEG- EPS next Q-0.77 Inst Own4.76% Short Float14.20% Perf Quarter-31.15%
Sales3.09M P/S7.69 EPS this Y67.39% Inst Trans128.60% Short Ratio0.77 Perf Half Y56.52%
Book/sh0.99 P/B2.55 EPS next Y75.06% ROA-178.10% Short Interest1.33M Perf Year-58.00%
Cash/sh0.91 P/C2.77 EPS next 5Y- ROE-276.02% 52W Range1.09 - 11.18 Perf YTD-53.46%
Dividend Est.- P/FCF- EPS past 5Y92.12% ROI-286.01% 52W High-77.46% Beta3.32
Dividend TTM- Quick Ratio4.17 Sales past 5Y-20.34% Gross Margin96.90% 52W Low131.17% ATR (14)0.30
Dividend Ex-Date- Current Ratio4.17 EPS Y/Y TTM31.46% Oper. Margin-792.63% RSI (14)50.43 Volatility9.67% 14.95%
Employees17 Debt/Eq0.00 Sales Y/Y TTM-100.00% Profit Margin-787.08% Recom1.00 Target Price14.60
Option/ShortNo / Yes LT Debt/Eq0.00 EPS Q/Q80.89% Payout- Rel Volume0.59 Prev Close2.19
Sales Surprise108.91% EPS Surprise30.85% Sales Q/Q- EarningsNov 12 AMC Avg Volume1.74M Price2.52
SMA20-5.23% SMA509.38% SMA2002.97% Trades Volume1,032,694 Change15.07%
Date Action Analyst Rating Change Price Target Change
Nov-11-24Initiated Alliance Global Partners Buy $15
Jul-16-24Initiated ROTH MKM Buy $20
Nov-19-20Initiated Maxim Group Buy $8
Nov-26-24 09:00AM
Nov-19-24 09:00AM
Nov-12-24 04:00PM
07:07AM
Nov-05-24 09:00AM
09:00AM Loading…
Oct-02-24 09:00AM
Sep-25-24 07:00AM
Sep-24-24 07:00AM
Sep-03-24 11:54PM
09:00AM
Sep-02-24 12:17PM
Aug-28-24 08:59PM
Aug-21-24 09:00AM
07:00AM
Aug-20-24 07:45AM
07:00AM Loading…
07:00AM
Aug-19-24 05:16PM
Aug-15-24 09:00AM
Aug-08-24 09:00AM
Aug-06-24 04:00PM
Jul-31-24 10:15AM
09:00AM
Jul-30-24 09:00AM
Jul-17-24 07:00AM
Jul-16-24 12:54PM
09:00AM
07:00AM
Jul-11-24 08:30AM
Jul-09-24 09:00AM
Jun-27-24 02:23PM
09:00AM Loading…
09:00AM
07:34AM
Jun-26-24 07:41AM
Jun-20-24 10:00AM
Jun-18-24 07:00AM
Jun-07-24 07:22AM
May-29-24 09:00AM
May-17-24 08:00AM
May-15-24 08:19AM
07:53AM
May-14-24 04:00PM
May-07-24 09:00AM
Apr-04-24 12:30PM
Mar-28-24 09:00AM
Mar-12-24 09:00AM
Mar-06-24 09:00AM
Mar-02-24 08:45AM
Feb-29-24 04:00PM
Feb-22-24 09:00AM
Feb-19-24 09:00AM
Feb-13-24 09:00AM
Feb-06-24 09:00AM
Jan-29-24 09:00AM
Jan-08-24 09:00AM
Jan-04-24 09:00AM
Jan-03-24 09:00AM
Dec-27-23 09:00AM
Dec-19-23 09:00AM
Dec-06-23 07:00AM
Dec-05-23 07:00AM
Nov-30-23 04:30PM
Nov-29-23 09:00AM
Nov-28-23 09:00AM
Nov-14-23 09:00AM
Nov-10-23 10:24AM
Nov-08-23 04:00PM
Nov-01-23 07:00AM
Oct-31-23 09:00AM
07:00AM
Oct-30-23 09:00AM
Oct-25-23 09:00AM
Oct-24-23 09:00AM
Oct-09-23 09:00AM
Oct-05-23 09:00AM
Oct-04-23 07:00AM
Oct-03-23 07:00AM
Sep-27-23 09:00AM
Sep-26-23 09:00AM
Sep-21-23 09:35AM
Sep-20-23 09:00AM
Sep-19-23 09:00AM
Sep-12-23 09:00AM
Sep-11-23 09:00AM
Aug-31-23 09:00AM
Aug-29-23 09:00AM
Aug-28-23 09:00AM
Aug-11-23 12:47PM
Aug-10-23 09:00AM
Aug-09-23 04:00PM
Jul-26-23 09:00AM
Jul-24-23 09:00AM
Jul-20-23 09:00AM
Jul-10-23 09:00AM
Jun-28-23 09:00AM
Jun-27-23 10:15AM
May-31-23 09:00AM
May-25-23 09:00AM
May-24-23 04:32PM
08:00AM
May-15-23 09:00AM
GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. It focuses on preventive vaccines against hemorrhagic fever viruses such as Ebola, Sudan, Marburg, and Lassa fever, the Zika virus and malaria, and human immunodeficiency virus, as well as immunotherapies for solid tumor cancers. The company was founded in June 1988 and is headquartered in Smyrna, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DODD DAVID APresident, CEOAug 09 '24Buy1.958,00015,60026,661Aug 12 08:47 AM
DODD DAVID APresident, CEOFeb 22 '24Buy2.278,20918,66318,661Feb 22 04:41 PM
DODD DAVID APresident, CEOFeb 21 '24Buy2.155201,11810,452Feb 22 04:41 PM
Reynolds MarkCFOFeb 07 '24Buy2.772,0005,5407,213Feb 07 04:43 PM
McKee Kelly T. Jr.Chief Medical OfficerDec 22 '23Buy0.366,9442,50035,782Dec 26 03:51 PM